The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
Abstract
Background Depression is an independent risk factor for myocardial infarction (MI). Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of serotonin-mediated platelet activation in addition to treatment of depression itself. Methods and Results A case-control study of first MI in smokers 30 to 65 years of age was conducted among all 68 hospitals in an 8-county area during a 28-month period. Cases were patients hospitalized with a first MI. Approximately 4 community control subjects per case were randomly selected from the same geographic area using random digit dialing. Detailed information regarding use of antidepressant medication as well as other clinical and demographic data were obtained by telephone interview. A total of 653 cases of first MI and 2990 control subjects participated. After adjustment, using multivariable logistic regression, for age, sex, race, education, exercise, quantity smoked per day, body mass index, aspirin use, family history of MI, number of physician encounters, and history of coronary disease, diabetes, hypertension, or hypercholesterolemia, the odds ratio for MI among current SSRI users compared with nonusers was 0.35 (95% CI 0.18, 0.68; P <0.01). Non-SSRI antidepressant users had a nonsignificant reduction in MI risk with wide confidence intervals (adjusted odds ratio 0.48, CI 0.17, 1.32; P =0.15). However, analysis of this group was limited by the small number of exposed subjects. Conclusions The use of SSRIs may confer a protective effect against MI. This could be attributable to the inhibitory effect SSRIs have on serotonin-mediated platelet activation or possibly amelioration of other factors associated with increased risk for MI in depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION
MICKEY, R. M., & GREENLAND, S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115101 · Cited by 2,362
RE:“;THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION”
Greenland, S., & Mickey, R. M. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115409 · Cited by 2,108
Depression and 18-Month Prognosis After Myocardial Infarction
Frasure-Smith, N., Lespérance, F., & Talajic, M. (1995) · Circulation · doi:10.1161/01.cir.91.4.999 · Cited by 1,549
The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.580 · Cited by 1,532
Pratt, L. A., Ford, D. E., Crum, R. M., Armenian, H. K., Gallo, J. J., & Eaton, W. W. (1996) · Circulation · doi:10.1161/01.cir.94.12.3123 · Cited by 643
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
Ariyo, A. A., Haan, M., Tangen, C. M., Rutledge, J. C., Cushman, M., Dobs, A., & Furberg, C. D. (2000) · Circulation · doi:10.1161/01.cir.102.15.1773 · Cited by 556
de Abajo, F. J., Rodriguez, L. A. G., & Montero, D. (1999) · BMJ · doi:10.1136/bmj.319.7217.1106 · Cited by 454
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose, S. P. (1998) · JAMA · doi:10.1001/jama.279.4.287 · Cited by 453
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Cohen, H. W., Gibson, G., & Alderman, M. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00301-0 · Cited by 390
Laghrissi-Thode, F., Wagner, W. R., Pollock, B. G., Johnson, P. C., & Finkel, M. S. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00345-9 · Cited by 347
The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus
Kahn, S. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00336-3 · Cited by 242
Paroxetine decreases platelet serotonin storage and platelet function in human beings
Hergovich, N. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110456 · Cited by 229
Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease
Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., & Bigger, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.660 · Cited by 212
Platelet Reactivity in Depressed Patients Treated With Paroxetine: Preliminary Findings
Musselman, D. L., Marzec, U. M., Manatunga, A., Penna, S., Reemsnyder, A., Knight, B. T., Baron, A., Hanson, S. R., & Nemeroff, C. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.875 · Cited by 205
Arora, R. C., & Meltzer, H. Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90384-6 · Cited by 175
Shapiro, P. A., Lespérance, F., Frasure-Smith, N., O'Connor, C. M., Baker, B., Jiang, J. W., Dorian, P., Harrison, W., & Glassman, A. H. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70369-8 · Cited by 159
Platelet Activation in Depression and Effects of Sertraline Treatment: An Open-Label Study
Markovitz, J. H., Shuster, J. L., Chitwood, W. S., May, R., & Tolbert, L. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.1006 · Cited by 149
The use of antidepressant drugs in patients with heart disease.
Glassman, A. H., Rodríguez, A. I. E., & Shapiro, P. A. (1998) · PubMed · Cited by 125
Bleeding attributed to the intake of paroxetine
Ottervanger, J. P., Stricker, B. H. C., Huls, J., & Weeda, J. N. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.781 · Cited by 89
Risk of acute first myocardial infarction and use of nicotine patches in a general population
Kimmel, S. E., Berlin, J. A., Miles, C., Jaskowiak, J., Carson, J. L., & Strom, B. L. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01124-x · Cited by 85
Self-citationBleeding, a side effect of fluoxetine
Aranth, J., & Lindberg, C. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.3.412a · Cited by 72
Fluoxetine and bleeding in obsessive-compulsive disorder
Yaryura-Tobias, J. A., Kirschen, H., Ninan, P. T., & Mosberg, H. J. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.949b · Cited by 70
Nair, G. V., Gurbel, P. A., O’Connor, C. M., Gattis, W. A., Murugesan, S. R., & Serebruany, V. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00284-2 · Cited by 64
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets
Helmeste, D. M., Tang, S. W., Reist, C., et al. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90051-9 · Cited by 56
Prolonged bleeding time in a patient treated with sertraline
Calhoun, J. W., & Calhoun, D. D. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.443a · Cited by 55
Diagnostic Criteria for Hospitalized Acute Myocardial Infarction: The Minnesota Experience
Mascioli, S. R., Jacobs, D. R., & Kottke, T. E. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.76 · Cited by 48
Is the Use of Psychotropic Drugs Associated with Increased Risk of Ischemic Heart Disease?
Lapane, K. L., Zierkr, S., Lasater, T. M., Barbour, M. M., Carleton, R. A., & Hume, A. L. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00008 · Cited by 45
Delisi, S., Konopka, L. M., O'Connor, F. L., & Crayton, J. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00377-6 · Cited by 39
Sallee, F. R., Hilal, R. E., DOUGHERTY, D., BEACH, K., & Nesbitt, L. A. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199807000-00018 · Cited by 39
Cited by
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.012 · Cited by 1,286
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice
Rozanski, A., Blumenthal, J. A., Davidson, K. W., Saab, P. G., & Kubzansky, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.005 · Cited by 1,238
Metadata
- Authors
- Sauer, W. H., Berlin, J. A., & Kimmel, S. E.
- Venue
- Circulation
- Published
- 2001-10-16
- Volume
- 104
- Issue
- 16
- Pages
- 1894-1898
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1988646408
- Cited by
- 319
- References
- 34
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.